Chengdu Bio-Town Sci-Tech Service Company Files IPO Prospectus: Driving Innovation and Full Occupancy in Biopharmaceutical Park Development

Chengdu Bio-city Science and Technology Service Company has comprehensively implemented the action plan deployed by the Chengdu Municipal Party Committee and Municipal Government, which focuses on “optimizing quality, establishing distinctive parks, empowering efficiency gains, and filling parks with enterprises.” Centering on five key priority tasks, the company adheres to innovation-led development, aggregates scientific and technological innovation resources, and enhances the effectiveness of science and technology services. By continuously deepening practices in scientific and technological innovation, Chengdu Bio-city Science and Technology Service Company has steadily built a vibrant and efficiently collaborative industrial park ecosystem, injecting sustained momentum into the high-quality development of the park.

As a practitioner in the comprehensive operation of the Bio-City park, Chengdu Bio-City Science and Technology Service Company has been committed to building a favorable environment and platform to support startups, promoting the transformation of scientific and technological achievements and the development of innovation and entrepreneurship. Bio-Link Biomedical Incubator, an incubation and innovation platform developed and operated by Chengdu Bio-City Science and Technology Service Company, adheres to the service philosophy of “innovation empowerment and strengthening/supplementing the industrial chain.” By establishing a science and technology service platform and a professional technical service platform, it addresses the needs of high-tech innovative enterprises in fields such as cell and gene therapy, precision medicine, and high-performance medical devices. It constructs a full-chain, tiered cultivation system spanning early-stage incubation, pilot-scale R&D, and commercial production, providing strong support for the development of the biomedical industry and facilitating the rapid growth of incubated enterprises.

① Promote Innovation, Empower Growth, and Accelerate High-Quality Development of Incubated Enterprises:

Bio-Link Biopharmaceutical Incubator boasts a professional service team dedicated to providing resident enterprises with a superior incubation environment, comprehensive incubation services, and personalized entrepreneurial coaching, thereby facilitating rapid growth and successful product commercialization. Benchmarking against renowned incubation brands both domestically and internationally, the team has strategically developed specialized incubators focused on biopharmaceuticals, medical devices, nuclear medicine, and biological breeding.

▶ Provide professional incubation carriers for startups, and build specialized public technology platforms to facilitate the commercialization and pilot-scale maturation of enterprise projects;

▶ Collaborated with professional investment institutions such as Daoyuan Capital and Guosheng Capital to establish an angel fund, providing investment and financing services for incubated enterprises;

▶ Build an integrated online-offline industrial service platform to actively aggregate and match more high-quality, specialized third-party service resources for incubated enterprises;

By laying a solid industrial foundation and empowering innovation, Chengdu Bio-City Science & Technology Service Company has established the “Bio-Link” incubation brand. Through practical guidance in building its cultivation system, it has gradually developed and refined an innovative cultivation framework for the biopharmaceutical industry, integrating “incubation carriers + public technology platforms + angel funds + incubation services,” thereby creating an industrial ecosystem characterized by resource sharing, achievement demonstration, and sustainable growth.

② Build systems, expand networks, and broaden channels for project introduction:

To better serve incubated enterprises, Chengdu Biological Town Science and Technology Service Company has actively explored channels for introducing incubation projects. It has established close ties with renowned universities through on-site visits and discussions to seek cooperation opportunities, expand investment promotion channels for incubation projects, inject university innovation resources, and promote innovative development within the park. Meanwhile, the company has strengthened upward linkages by coordinating with provincial and municipal authorities, such as the Departments of Science and Technology and Economy and Information Technology, to facilitate enterprise development. This effort aims to open communication channels between the park and enterprises, assisting them in obtaining relevant qualifications and applying for subsidies.

▶In March 2023, Usenobio, an incubatee of the Bio-Link Biomedical Incubator, won the top prize at the National Disruptive Technology Innovation Competition organized by the Ministry of Science and Technology;

▶ At the 12th China Innovation and Entrepreneurship Competition hosted by the Ministry of Science and Technology in 2023, YouSaino Bio and LingTaiKe Bio, incubatees of the Bio-Link Biomedical Incubator, secured the first and third places, respectively, in the Sichuan Provincial Growth Group, while Micellon Bio won the first place in the Sichuan Provincial Startup Group. Zhishan Weixin Bio, a company based in the park, advanced to the finals, marking the first time a biomedical project from Sichuan Province has reached the finals.

▶ Successfully cultivated two provincial-level “Specialized, Refined, Differential, and Innovative” (SRDI) enterprises, Useno and Lingtaike, marking the first batch of SRDI small and medium-sized enterprises independently incubated from “0 to 1.” This achievement establishes a biopharmaceutical innovation incubation system featuring gradient cultivation that spans early-stage incubation, pilot-scale R&D, and commercial production.

③ Establishing benchmarks to foster development, securing the first provincial-level qualification for professional industrial park operations:

Through the precise operations and dedicated services provided by Chengdu Bio-city Science & Technology Service Co., Ltd., Chengdu Tianfu International Bio-city successfully obtained the 2022 accreditation as a Sichuan Provincial Demonstration Base for Entrepreneurship and Innovation among Small and Micro Enterprises. This accreditation marks the first provincial-level qualification related to specialized industrial parks awarded to Bio-city Group since its establishment, holding significant importance for the park’s industrial operations, technological services, and incubation innovation.

In 2023, Bio-Link Biomedical Incubator was approved and filed as a specialized incubator for technology enterprises by Sichuan Province, becoming the first provincial-level incubator in Chengdu Biological Town. This also marked the first professional qualification for technology incubation operations obtained by Chengdu Biological Town Science and Technology Service Co., Ltd. The acquisition of this provincial-level incubator operation qualification not only demonstrates that the professional capabilities and extensive experience of Chengdu Biological Town Science and Technology Service Co., Ltd. in incubator management and services have gained broader recognition, but also further expands the company’s influence in the incubation sector, driving the vigorous development of technological innovation within Chengdu Biological Town.

To date, incubated projects at the Bio-Link Biomedical Incubator have secured over RMB 420 million in financing, with a total valuation exceeding RMB 3 billion. The incubator has cumulatively introduced and nurtured more than 40 projects, including Psyray Biotechnology, NanoCrystal Technologies, Shiguihang Pharmaceutical, Beige Exploration, and Zhisaiyuanji Biology, contributing scientific and technological services to the development of the biomedical industry.

Thriving Industrial Parks Drive Industrial Prosperity; Strong Industrial Parks Bolster Economic Strength! In recent years, Chengdu Biological Town has continuously improved the construction of basic supporting facilities in its industrial parks and enhanced their capacity to host industries, laying a solid foundation for high-quality development. Through multiple measures and coordinated efforts, Chengdu Biological Town Science and Technology Service Company has attracted numerous high-quality enterprises with its robust infrastructure and professional services, effectively accelerating park development and fostering industrial clustering.

▶ From 2022 to 2023, the investment promotion team of Chengdu Bio-city Science and Technology Service Company continuously followed up on the needs of Xinchaoyang, a leading enterprise in the biological breeding industry. The team accompanied the company on multiple site visits and provided detailed introductions to the available facilities and surrounding environment. The well-developed public amenities and full-chain settlement services offered by Bio-city instilled confidence in the company to establish its presence there.

▶ During business negotiations, the investment promotion team of Chengdu Bio-city Science and Technology Service Company proactively aligned with government policies and coordinated group resources to identify the optimal settlement pathway for the enterprise. At critical stages of project advancement, the team conducted multiple on-site visits and held face-to-face discussions with the company’s leadership to address concerns and reinforce their confidence in establishing operations at the park.

▶ Ultimately, the company successfully completed the signing in December 2023, which not only addressed its space requirements for R&D and office operations but also injected new momentum into the development of the industrial park.

As of October 2024, Chengdu Biological City Science and Technology Service Company has cumulatively attracted approximately 150 enterprises and gathered more than 5,000 industrial talents.

Chengdu Tianfu International Bio-Town’s Bio-Service Technology Service Platform was launched and became operational in 2023. Currently, it offers more than 160 services, including Bio-Loans, hazardous waste entry/exit management, equipment sharing, policy updates, bill inquiries, testing and inspection, registration and approval assistance, and financial and tax consulting. This comprehensive service matrix covers the entire lifecycle of pharmaceutical and medical device enterprises, helping to accelerate their R&D progress.

▶In supporting enterprises to reduce costs and enhance efficiency, the Bio-Service Technology Platform has facilitated “joint transportation of hazardous waste.” This initiative has transformed the traditional model where enterprises individually arranged for their own hazardous waste disposal and transportation, achieving instead a consolidated approach that aggregates scattered small-volume generators, combines fragmented shipments into full loads, ensures comprehensive collection, and implements standardized management. As a result, unit transportation costs have been significantly reduced, and transportation efficiency has improved. More than 50 enterprises within the industrial park have participated, cumulatively transporting over 350 tons of hazardous waste and helping companies save more than RMB 1.05 million in transportation costs.

▶To enhance the efficiency of corporate resource utilization, the Bio-Service technology service platform has launched an instrument-sharing feature. The platform catalogs over 800 types of instruments and equipment from shared laboratory platforms, including park-based enterprises such as Ucell Therapeutics, Eurofins, and Tofflon, as well as Parallel Labs and the Bio-Link Incubator. This initiative helps companies like HitGen match with shared instruments within the park that meet their experimental needs, gradually forming a closed-loop ecosystem and facilitating resource sharing among enterprises.

As of October 2024, the Bio-Service Technology Service Platform at Chengdu Tianfu International Bio-City had onboarded 223 service institutions, registered over 5,000 users, and provided more than 26,000 services to enterprises.

The Supply Chain Service Center is a vital component of the Tianfu International Bio-town’s public service platform. Anchored in the Tianfu International Bio-town and leveraging the strategic advantages of Chengdu’s China-Europe Railway Express departure hub and its dual-airport system, the Center has established specialized service segments including cross-border pharmaceutical transportation, customs clearance, information services, and pharmaceutical distribution. It provides international and domestic pharmaceutical and medical device enterprises with a comprehensive, end-to-end “door-to-door” pharmaceutical supply chain service system.

Since its launch, the Supply Chain Service Center has served numerous domestic and international pharmaceutical and medical device companies, earning high acclaim for its rapid and professional services.

▶In August 2023, the automated testing equipment for international export services, provided by the Supply Chain Company to Hanchen Guangyi, a park-based enterprise, successfully completed customs clearance in Chengdu and was flown from Wuhan Tianhe International Airport to São Paulo/Guarulhos International Airport in Brazil. The exported products consisted of the high-throughput genotyping system Gene Matrix and its accessories (10 items in total), which were picked up on August 19 from Hanchen Guangyi’s factory in the Bio-Town and transported to the Wuhan port. This marked the first time the Supply Chain Company had provided export services for complete sets of life science equipment for enterprises in the Bio-Town. Since then, the Supply Chain Company has repeatedly facilitated the overseas expansion of Hanchen Guangyi’s equipment, achieving an export value of approximately RMB 20 million.

▶ This July, the supply chain company leveraged the advantages of its supply chain service platform to help U-Sino, a tenant enterprise in Bio-City, achieve China’s first breakthrough in the importation of umbilical cord blood stem cells, thereby safeguarding the innovative drug R&D efforts of park-based enterprises.

Chengdu Bio-City Science and Technology Services Company consistently implements the work requirements of “visiting ten thousand enterprises, resolving difficulties, optimizing the business environment, and promoting development.” By focusing on corporate development needs, it addresses enterprise challenges, strengthens confidence in growth, and stimulates innovation-driven momentum.

Enterprises may encounter a series of challenges during their development, such as difficulties in interpreting policies, applying for policy-based programs, and securing financing. To comprehensively meet the developmental needs of enterprises, Chengdu Bio-city Science and Technology Service Company has adopted a multi-dimensional approach encompassing policy dissemination, interpretation, consultation, and training, thereby effectively bridging the “last mile” of policy services through concrete actions.

① Interpreting policies to support the long-term development of enterprises:

To date, Chengdu Bio-city Science and Technology Service Co., Ltd. has served over 50 enterprises in 2024, providing more than 200 policy consultation and interpretation services.

▶ Assisted over 20 enterprises in applying for recognition as High-Tech Enterprises and Specialized, Refined, Differential, and Innovative (SRDI) enterprises. Among them, one enterprise was awarded the national-level “Little Giant” title, 13 were recognized as provincial-level SRDI enterprises, six were newly added to the list of Innovative Small and Medium-sized Enterprises, 40 were included in the pool of Technology-based Small and Medium-sized Enterprises, and six were newly certified as National High-Tech Enterprises.

▶ Assisted 22 enterprises in completing the application for the 2024 rental subsidy for production and business operation premises of small and micro-sized enterprises, with a total declared amount exceeding RMB 3 million.

▶ Conduct two special policy training sessions, effectively promote general park policies and real-time new regulations, and strive to ensure that enterprises are fully aware of all applicable policies.

In addition to launching policy-related features, Chengdu Bio-City Science and Technology Service Company has leveraged information technology through its Bio-Service Sci-Tech Service Platform to provide online policy inquiry and appointment scheduling capabilities, enabling timely notifications. By integrating corporate operational profiles for precise matching, the company has facilitated a shift from “companies seeking policies” to “policies seeking companies,” truly achieving convenient, intelligent, and efficient services.

② Professional Guidance to Assist Enterprises in Scientific Application:

To promote the high-quality development of enterprises in the industrial park, Chengdu Bio-City Science and Technology Service Company has actively played a leading role. By focusing on enterprise needs, it has conducted comprehensive analyses of the difficulties in application processes, provided key interpretations of policy changes, and helped businesses accurately understand and master the various standards and requirements for policy certification. The company has tailored “success guides” for each enterprise, effectively promoting a dual improvement in both the quantity and quality of “Specialized, Refined, Differential, and Innovative” (SRDI) enterprises within the park.

▶ Tekelo Biotechnology (Chengdu) Co., Ltd. relocated from Jiaxing to the Bio-town in 2023. As a newly established enterprise, it was unfamiliar with provincial and municipal policies. During the application period for “Specialized, Refined, Differential, and Innovative” (SRDI) enterprises, a policy service specialist from Chengdu Bio-town Scientific Service Company proactively contacted the company’s liaison, informed them that they met the criteria for the policy “fast track,” recommended that they apply, and provided detailed information on the application process and recognition rewards. Upon learning this, the company promptly began preparing the necessary materials, and all issues encountered during the application were resolved with the assistance of the policy service specialist. In August of this year, the company was successfully recognized as a provincial-level SRDI enterprise.

③ Robust Finance: Resolving Corporate Financing Challenges

Park enterprises seeking to expand operations and ramp up production may face a series of challenges, including cash flow constraints, high financing thresholds, and cumbersome approval procedures. To address these financing needs, Chengdu Bio-town has launched the “Bio-Loan” series of debt products, aiming to resolve the difficulties and high costs associated with corporate financing and support enterprises in scaling up their production. Chengdu Bio-town Science and Technology Service Co., Ltd. has built a bridge between banks and enterprises through its Bio-Service technology platform, enabling companies to quickly apply for the “Bio-Loan” product series. This initiative has effectively reduced corporate financing costs, accelerating project construction and ensuring smooth implementation.

▶Since its establishment in May 2021, the “Bio Series Loan” program has partnered with institutions including Bank of Chengdu, China Merchants Bank, Industrial Bank, Bank of China, Chengdu Rural Commercial Bank, and China Construction Bank.

▶ Successfully secured nearly RMB 50 million in credit lines for park-based enterprises, including Bio-Tech (Bo'ao Teke) and Sichuan Anaerobic Biotech.

As of August 2024, 45 companies in the industrial park had applied for Bio-Loans, securing over RMB 1 billion in bank credit lines through the platform.

In recent years, Chengdu Biological City Science and Technology Service Company has consistently focused on addressing the urgent needs and pressing concerns of tenant enterprises. By proactively providing front-line services, it has resolved “difficult challenges” and alleviated “pain points,” making concerted efforts to tackle the “growing pains” of small and medium-sized enterprises (SMEs). Through concrete actions, the company has helped accelerate business development and enhance operational efficiency.

① Build a professional testing platform to provide high-quality and efficient testing services:

Testing services are a core component in ensuring the smooth progression of corporate R&D and production. By leveraging feedback from test results, companies can assess the current status of their R&D efforts and make targeted adjustments. To deliver exceptional and efficient testing services, Chengdu Bio-Town Scientific Service Company is committed to building a professional testing platform, thereby adding a crucial link to the biomedical industry chain.

In May 2024, Chengdu Bio-City Science and Technology Service Company, in collaboration with Zhongke Puyan (Chengdu) Testing Co., Ltd., successfully passed the ISO/IEC 17025:2017 system assessment and obtained authoritative CNAS accreditation. During the preparation phase, Chengdu Bio-City Science and Technology Service Company provided full support to the enterprise in preparing for and attending the on-site assessment, thereby facilitating the successful acquisition of this important accreditation.

② Address corporate pain points to facilitate rapid business growth.

In its daily operations, Chengdu Bio-town Science and Technology Service Company has proactively responded to corporate needs, continuously enhancing its service standards and capabilities to address challenges and provide robust logistical support for business development.

▶In December 2023, a company incubated at the Parallel Laboratory was in a critical phase of producing samples for clinical trial applications, but production was hindered by issues with industrial steam supply. Upon learning of the situation, Chengdu Bio-city Science and Technology Service Company swiftly took action by coordinating with Kunlun Energy to restore the industrial steam supply, thereby enabling the successful production of the clinical trial application samples.

▶In June 2024, the company formally submitted its clinical trial application to the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA).

Industrial parks are not just about production; they are also about living. Chengdu Bio-town Science and Technology Services Company has consistently upheld the “industry-city integration” development philosophy of Bio-town, aiming to build a specialized industrial park with distinctive features that is vibrant, dynamic, and charming, thereby providing comprehensive and diversified work-life experiences for employees of companies within the park.

▶ Early this summer, Chengdu Bio-City Science Service Company brought a special “Float Market” to the park, bringing forest greenery into the campus so that employees could enjoy flower seas, savor delicious food, and relish leisurely moments amidst their busy schedules.

▶ This Mid-Autumn Festival, Chengdu Biological City Science and Technology Service Company held a themed market event titled “Welcoming the Mid-Autumn Festival with Grace in Yong’an.” The event attracted over 1,000 corporate employees. While immersively experiencing the charm of Yong’an’s traditional culture, participants also facilitated communication and exchange platforms for enterprises and local merchants in the Biological City area, significantly promoting the integration and coordinated development of industry and urban life between the Biological City Park and Yong’an Town.

In the future, Chengdu Bio-city Science and Technology Service Company will continue to implement the requirements of the “Establishing a Full Park” initiative, deepen its focus on park operations, enhance service quality, optimize service efficiency, deploy a comprehensive suite of corporate services, accelerate enterprise development, and continuously stimulate the park’s innovation vitality and endogenous momentum. The company is committed to building the park into the primary battleground and main engine for the high-quality development of the biopharmaceutical industry.